Retiree family calls on SFHSS to override Blue Shield denial for life-saving cancer treatment

Helen Horvath, a retired San Francisco firefighter-paramedic, told the Health Service Board that her husband, retired firefighter Ken Jones, has fast-growing stage 4 metastatic lung cancer and that Blue Shield has denied the UCSF oncologist'recommended treatment that could slow disease progression. "Blue Shield is denying the treatment recommended by Ken's oncologist at UCSF," Horvath said, adding the denials have drained the medical team and threatened Ken's life.

Rachel Jones, Ken Jones's daughter and a registered nurse, asked the board to override the insurer's denials and called the situation "not a difference of medical opinion" but a decision that will cause faster decline and unnecessary suffering. "Blue Shield is not practicing medicine here. It is practicing cost cutting at the direct expense of my father's life," she said.

Former SFFD Chief Janine Nicholson and representatives from Protect Our Benefits reinforced that this is a systemic problem affecting active and retired firefighters. Nicholson said the pattern of denials reflects a broader failure and urged the board and SFHSS leadership to "use every tool in your toolbox to fix this." Fred Sanchez of Protect Our Benefits asked trustees, as fiduciaries, to hold Blue Shield accountable to its contractual commitments.

Supervisor Aaron Dorsey, the Board of Supervisors' representative to SFHSS, told the board he shared the speakers' concerns and said he would confer with board colleagues and the city attorney's office about using the Board of Supervisors' review powers — including hearings, letters of inquiry, or subpoenas — to investigate whether Blue Shield's practices constitute a diminution of service from what was represented during the RFP process.

No formal action was taken on the public comments. Board members thanked speakers and noted the concerns would be tracked; Supervisor Dorsey indicated the Board of Supervisors may pursue further review if warranted.

The most recent factual development is that the board acknowledged the public comment and committed to follow-up; no vote or override of the insurer was recorded at this meeting.